Covestor LTD Neogenomics Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Neogenomics Inc stock. As of the latest transaction made, Covestor LTD holds 10 shares of NEO stock, worth $139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 10 -0.0%

Holding current value

$139

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$13.01 - $15.77 $26 - $31	2 Added 25.0%	10 $0
Q1 2024 May 10, 2024	SELL	$14.06 - $16.79 $14 - $16	-1 Reduced 11.11%	8 $0
Q4 2023 Feb 09, 2024	SELL	$11.67 - $20.73 $11 - $20	-1 Reduced 10.0%	9 $0
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $12 - $17	-1 Reduced 9.09%	10 $0
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $84 - $118	-6 Reduced 35.29%	11 $0
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $6 - $12	-1 Reduced 5.56%	17 $0
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $31 - $51	-4 Reduced 18.18%	18 $0
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $1,051 - $2,081	-149 Reduced 87.13%	22 $0
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $400 - $1,164	-33 Reduced 16.18%	171 $2,000
Q4 2021 Feb 10, 2022	BUY	$30.49 - $48.49 $6,219 - $9,891	204 New	204 $7,000

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$275 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$196 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$96.3 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$92.3 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$91.4 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.76B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account